Hepatic and extra-hepatic metabolic pathways involved in flubendazole biotransformation in sheep

Biochemical Pharmacology

Volumn 76, Issue 6, 2008, Pages 773-783

  Maté, Laura ^a,b   Virkel, Guillermo ^a,b   Lifschitz, Adrián ^a,b   Ballent, Mariana ^a,b   Lanusse, Carlos ^a,b  

^a UNIVERSIDAD NACIONAL DEL CENTRO DE LA PROVINCIA DE BUENOS AIRES   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Anthelmintics; Biotransformation; Carbonyl reductase; Flubendazole; Microsomes; Sheep

Indexed keywords

CARBONYL REDUCTASE; CYTOCHROME P450; FLUBENDAZOLE; MENADIONE; PHENOBARBITAL; PIPERONYL BUTOXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; WARFARIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL FRACTIONATION; CONTROLLED STUDY; DRUG METABOLISM; DRUG TRANSFORMATION; DUODENUM MUCOSA; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; LIVER CYTOSOL; LIVER MICROSOME; NONHUMAN; PRIORITY JOURNAL; RAT; REDUCTION; SHEEP;

ANIMALS; BIOTRANSFORMATION; DUODENUM; FEMALE; INTESTINAL MUCOSA; MALE; MEBENDAZOLE; MICROSOMES, LIVER; RANDOM ALLOCATION; RATS; SHEEP, DOMESTIC; STOMACH, RUMINANT;

EID: 50849103632     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2008.07.002     Document Type: Article

References (45)

1. Lin J., Chiba M., and Baillie T. Is the role of the small intestine in first-pass metabolism overemphasized?. Pharmacol Rev 51 (1999) 135-158
2. Prins R. Rumen microbial metabolism of plant secondary compounds, xenobiotics and drugs. In: Ooms L., Degryse A., and van Miert A. (Eds). Physiological and pharmacological aspects of the reticulo-rumen (1987), Martinus Nijhoff Publishers, Dordrecht, Netherlands 199-225
3. Russell J., and Rychlik J. Factors that alter rumen microbial ecology. Science 292 (2001) 1119-1122
4. Acosta de Pérez O., Bernacchi A., Diaz de Toranzo E., and Castro J. Reductive biotransformation of xenobiotics by the sheep ruminal content. Comp Biochem Physiol 101 (1992) 625-626
5. Lanusse C., Nare B., Gascon L., and Prichard R. Bioconversion of netobimin pro-drug by gastrointestinal fluids of ruminants. Eur J Drug Metab Pharmacokinet 17 (1992) 121-128
6. Renwick A., Strong H., and George C. The role of the gut flora in the reduction of sulfoxide containing drugs. Biochem Pharmacol 35 (1986) 64
7. Rowland I. Reduction by the gut microflora of animals and man. Biochem Pharmacol 35 (1986) 27-32
8. Galtier P., Alvinerie M., and Delatour P. In vitro sulfoxidation of albendazole by ovine liver microsomes: assay and frequency of various xenobiotics. Am J Vet Res 47 (1986) 447-450
9. Moroni P., Buronfosse T., Longin-Sauvageon C., Delatour P., and Benoit E. Chiral sulfoxidation of Albendazole by the flavin adenine dinucleotide-containing and cytochrome P-450 dependent monooxygenases from rat liver microsomes. Drug Metab Dispos 23 (1995) 160-165
10. Rawden H., Kokwaro G., Ward S., and Edwards G. Relative contribution of cytochromes P450 and flavin-containing monoxygenases to the metabolism of albendazole by human liver microsomes. Br J Clin Pharmacol 49 (2000) 313-322
11. Virkel G., Lifschitz A., Sallovitz J., Pis A., and Lanusse C. Comparative hepatic and extra-hepatic enantioselective sulphoxidation of albendazole and fenbendazole in sheep and cattle. Drug Metab Dispos 32 (2004) 536-544
12. Virkel G., Lifschitz A., Sallovitz J., Pis A., and Lanusse C. Assessment of the main metabolism pathways for the flukicidal compound triclabendazole in sheep. J Veterinary Pharmacol Therap 29 (2006) 213-223
13. Gottschall D., Theodorides V., and Wang R. The metabolism of benzimidazole anthelmintics. Parasitol Today 6 (1990) 118-124
14. Nobilis M., Jira T., Lisa M., Holčapek M., Szotáková B., Lamka J., et al. Achiral and chiral high-performance liquid chromatographic determination of flubendazole and its metabolites in biomatrices using UV photodiode-array and mass spectrometric detection. J Chromatogr A 1149 (2007) 112-120
15. Moreno L., Alvarez L., Mottier L., Virkel G., Sanchez Bruni S., and Lanusse C. Integrated pharmacological assessment of flubendazole potential for use in sheep: disposition kinetics, liver metabolism and parasite diffusion ability. J Vet Pharmacol Therap 27 (2004) 299-308
16. American Veterinary Medical Association. Report of the AVMA panel on euthanasia. J Am Vet Med Assoc 2001;218:669-96.
17. Nebbia C., Dacasto M., Rossetto Giaccherino A., Giuliano Albo A., and Carletti M. Comparative expression of liver cytochrome P450-dependent monooxigenases in the horse and in other agricultural and laboratory species. Vet J 165 (2003) 53-64
18. Lowry O., Rosebrough N., Farr A., and Randall R. Protein measurement with the folin phenol reagent. J Biol Chem 193 (1951) 265-275
19. Sivapathasundaram S., Magnisali P., Goldham N., Howells L., Sauer M., and Ioannides C. A study of the expression of the xenobiotics metabolising cytochrome P450 proteins and of testosterone metabolism in bovine liver. Biochem Pharmacol 62 (2001) 635-645
20. Lewis D.F.V. Molecular modeling of mammalian cytochromes P450. In: Ioannides C. (Ed). Cytochromes P450: metabolic and toxicological aspects (1996), CRC Press, Boca Raton, New York 355-398
21. Werringloer J. Assay of formaldehyde during microsomal oxidations reactions. Meth Enzymol 52 (1978) 297-302
22. Lanusse C., Nare B., Gascon L., and Prichard R. Metabolism of albendazole and albendazole sulphoxide by ruminal and intestinal fluids of sheep and cattle. Xenobiotica 22 4 (1992) 419-426
23. Delatour P., Benoit E., Garnier F., and Besse S. Chirality of the sulphoxide metabolites of fenbendazole and albendazole in sheep. J Vet Pharmacol Therap 13 (1990) 361-366
24. Hennessy D., Prichard R., and Steel J. Biliary secretion and enterohepatic recycling of fenbendazole metabolites in sheep. J Vet Pharmacol Therap 16 (1993) 132-140
25. Lanusse C., and Prichard R. Clinical pharmacokinetics and metabolism of benzimidazole anthelmintics in ruminants. Drug Metab Rev 25 (1993) 235-279
26. Virkel G., Lifschitz A., Pis A., and Lanusse C. In vitro ruminal biotransformation of benzimidazole sulphoxide enthelmintics: enantioselective sulphoreduction in sheep and cattle. J Vet Pharmacol Therap 25 (2002) 15-23
27. Forrest G., and Gonzalez B. Carbonyl reductase. Chem Biol Interact 129 (2000) 21-40
28. Gonzalez-Covarrubias V., Ghosh D., Lakhman S., Pendyala L., and Blanco J. A functional genetic polymorphism on human carbonyl reducates 1 (CBR V88I) impacts on catalytic activity and NADPH binding affinity. Drug Metab Dispos 35 (2007) 973-980
29. Testa B., and Mayer J. Stereoselective drug metabolism and its significance in drug research. Prog Drug Res 32 (1988) 249-303
30. Eyles D., McGrath J., Stedman T., and Pond S. Chiralty of reduced haloperidol in humans. Eur Neuropsychopharmacol 8 (1998) 127-129
31. Prelusky D., Coutts R., and Pasutto F. Stereospecific metabolic reduction of ketones. J Pharm Sci 71 (1982) 1390-1393
32. Strolin Benedetti M., Pianezzola E., Fraier D., Castelli M., and Dostert P. Stereoselectivity of idarubicin reduction in various animal species and humans. Xenobiotica 21 (1991) 473-480
33. Tyndale R., Kalow W., and Inaba T. Oxidation of reduced haloperidol to haloperidol: involvement of human P450IID6 (sparteine/debrisoquine monooxigenase). Br J Clin Pharmacol 31 (1991) 655-660
34. Souček P., and Gut I. Cytochrome P-450 in rats: structures, functions, properties and relevant human forms. Xenobiotica 22 1 (1992) 83-103
35. Waxman D.J., and Azaroff L. Phenobarbital induction of cytochrome P-450 gene expression. Biochem J 28 (1992) 577-592
36. Nims R.W., Lubet R.A., Fox S.D., Jones C.R., Thomas P.E., Reddy A.B., et al. Comparative pharmacodynamics of CYP2B induction by DDT, DDE and DDD in male rat liver and cultured rat hepatocytes. J Toxicol Environ Health (Part A) 53 (1998) 455-477
37. Lanusse C., Gascon L., and Prichard R. Influence of the antithyroid compound methimazole on the plasma disposition of fenbendazole and oxfendazole in sheep. Res Vet Sci 58 (1995) 222-226
38. Benchaoui H., and McKellar A. Interaction between fenbendazole and piperonyl butoxide: pharmacokinetic and pharmacodynamic implications. J Pharm Pharmacol 48 (1996) 753-759
39. Sánchez S., Small J., Jones D., and McKellar Q. Plasma achiral and chiral pharmacokinetic behaviour of intravenous oxfendazole co-administered with piperonyl butoxide in sheep. J Vet Pharmacol Therap 25 (2002) 7-13
40. Alvarez L., Sánchez S., and Lanusse C. In vivo and ex vivo uptake of albendazole and its sulphoxide metabolite by cestode parasites: relationship with their kinetic behaviour in sheep. J Vet Pharmacol Therap 22 (1999) 77-86
41. Alvarez L., Imperiale F., Sánchez S., Murno G., and Lanusse C. Uptake of albendazole sulphoxide by Haemonchus contortus and Fasciola hepatica in sheep. Vet Parasitol 94 (2000) 75-89
42. Lubega G., and Prichard R. Interaction of benzimidazole anthelmintics with Haemonchus contortus tubulin: binding affinity and anthelmintic efficacy. Exp Parasitol 73 (1991) 203-209
43. Gunning R. Inhibition of carbamate-insensitive acetylcholinesterase by piperonyl butoxide in Helicoverpa armigera. J Mol Neurosci 30 (2006) 21-22
44. Blagburn B., and Lindsay D. Ectoparasiticides. In: Adams R. (Ed). Veterinary pharmacology and therapeutics. 7th edition (1995), Iowa State University Press, Ames, Iowa, USA
45. Kotze A., Dobson R., and Chandler D. Synergism of rotenone by piperonyl butoxide in Haemonchus contortus and Trichostrongylus colubriformis in vitro: potential for drug-synergism through inhibition of nematode oxidative detoxification pathways. Vet Parasitol 136 (2006) 275-282